PDF

ReNu with MoistureLoc®

ReNu with MoistureLoc® Contact Lens Solution Litigation at The Lanier Law Firm

ReNu with Moisture Loc® cleanser was introduced to the market in late 2004 by Bausch & Lomb. This product was developed for soft contact lens wearers to condition their lenses to retain moisture while remaining clean for daily use. On April 13, 2006, Bausch & Lomb announced suspension of shipments of ReNu with Moisture Loc® due to reports of "fungal keratitis" infections in users of the solution.

Fungal keratitis is a serious eye infection that can develop through the whole depth of the cornea. Bausch & Lomb stated that February 18, 2006 was the earliest indication that there may be "an unusual occurrence with this infection" involving ReNu with Moisture Loc®. However, as reported by Reuters, Hong Kong authorities claim that they had noticed an increase in hospital admissions due to contact lens-related keratitis, and alerted Bausch & Lomb as early as November 2005.

On April 10, 2006, the CDC (Center for Disease Control) stated that it received reports of 109 cases of suspected fungal keratitis in 17 different states. Although the majority of patients have yet to be interviewed, the CDC confirmed that 28 of the 30, for whom complete information is available, wore soft contact lenses. The CDC also confirmed that 26 of those who used soft contact lenses reported using a Bausch & Lomb ReNu brand solution in the month prior to the onset of infection.

Both the CDC and the FDA continue to investigate reports of fungal keratitis in an effort to determine all contributing factors and/or products that place contact lens wearers at increased risk for infection.

If you or a loved one has used ReNu with Moisture Loc® and suffered any side effects, please contact our office for a free evaluation.

ReNu with Moisture Loc Information Links:

FDA Statement Regarding Voluntary Market Withdrawal of ReNu Moisture Loc

Preliminary Public Health Notification - Fungal Keratitis Infections Related to Contact Lens Use

FDA Advice to Patients

CDC Dispatch dated April 10, 2006